These are licensed prescription-only medicines approved by the MHRA and the European Medicines Agency (EMA) specifically for weight management in defined patient groups (see NICE TA875 for semaglutide and NICE TA664 for liraglutide)
Mechanism underlying the stimulation by IGF-1 of LHCGR expression in porcine granulosa [PMID: 33933758] Laboratory literature summary: Mechanism underlying the stimulation by IGF-1 of LHCGR expression in porcine granulosa cells
Once-weekly cagrilintide for weight management in people with overweight and obesity: A multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Many patients report better energy, mental clarity, and resilience after just a few sessions
Hyperplasia, hepatocellular (non-regenerative)no history or evidence of hepatocellular damage
Bile salt and fgf19 signaling in the early phase of human liver regeneration